The central purpose of the Del Monte Institute for Neuroscience is to reduce the burden of neurological and neuropsychiatric disease in our society through development of basic scientific knowledge and of novel therapeutic approaches. The institute exists to recognize new and emerging opportunities, to prosecute an aggressive innovative basic and translational research agenda, to build team science that tackles major problems from multi methodological and multi scalar perspectives, and to tackle fundamental neuroscientific questions that simply cannot be broached at the level of an individual laboratory or investigator—questions that demand concerted multi investigator teams. These are the so-called “wicked” problems of neuroscience, and the University of Rochester, through the efforts of the Del Monte Institute, will position itself to confront these challenges aggressively. We embrace as a core principle that it is only through fundamental understanding of the machinations of the brain that we can hope to provide effective evidence-based therapies to those suffering from severe mental illnesses and neurological disease.
A SIX-PRONGED STRATEGIC APPROACH
- Develop signature shared-resource space centered on model systems (cellular and molecular approaches, animal models, human patient-based investigations, and next- generation core facilities—what we have termed “the geography of integrative neuroscience.”
- Establish a highly efficient streamlined administrative office with advanced expertise in grants administration, project coordination, philanthropic development, community outreach, and media relations.
- Recruit key new faculty members to supplement and expand our centers of excellence by pursuing an interdepartmental coinvestment strategy.
- Seed and sustain programmatically focused centers of excellence around key basic science and clinical translational research topics and foster collaborative inter-disciplinary initiatives that remove traditional barriers between different fields of investigation. The four centers selected to date include
- The Rochester Alzheimer’s Disease Research Center (Kerry O’Banion and Anton Porsteinsson),
- The Intellectual and Developmental Disabilities Research Center (Tristram Smith and John Foxe),
- The Center for Health and Technology (Erika Augustine and Ray Dorsey), and
- The Center for Neural Augmentation and Virtual Reality (Edmund Lalor and Duje Tadin)
- Grow our diverse student and postdoctoral talent pool and provide innovative new training opportunities through the establishment of interdepartmental cross-disciplinary curricula.
- Project the institute onto the international stage through vigorous public relations and media efforts and establish the Del Monte Institute as a recognized International leader in neuroscience and neurotherapeutics.
John Foxe, Chair (SMD)
Kerry O’Banion (SMD)
Tristram Smith (SMD)
David Williams (AS&E)
Ray Dorsey (SMD)
Erika Augustine (SMD)
Greg DeAngelis (AS&E)
Duje Tadin (AS&E)
Ed Lalor (AS&E)
Laurel Carney (AS&E)
Liaisons to the Working Group
Advancement: Kellie Anderson, Senior Associate Vice President of University Advancement, URMC
Communications: Karl Withers, Associate Vice President, Marketing, URMC
Financial Sustainability: Bill Passalacqua, Senior Associate Dean, Finance & Administration, SMD